• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: EDWARDS LIFESCIENCES COSGROVE-EDWARDS ANNULOPLASTY SYSTEM; RING, ANNULOPLASTY

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

EDWARDS LIFESCIENCES COSGROVE-EDWARDS ANNULOPLASTY SYSTEM; RING, ANNULOPLASTY Back to Search Results
Model Number 4600
Device Problem Unintended Movement (3026)
Patient Problems Failure of Implant (1924); Mitral Regurgitation (1964); Regurgitation, Valvular (2335)
Event Date 08/02/2019
Event Type  Injury  
Manufacturer Narrative
(b)(4).The device was not returned to edwards for evaluation.The device history record (dhr) was reviewed and shows that this device met all manufacturing specifications for product release prior to distribution.No issues were identified that would have impacted this event.The causes of re-operation for a failed annuloplasty repairs are well documented in the literature.Re-operations are primarily the result of a progression of disease or technical failures and are not related to product malfunctions.Unlike prosthetic heart valves, annuloplasty rings are an adjunct to the valve repair.In this case, there was allegation of device malfunction.A manufacturing related issue was not identified.A definitive root cause could not be determined; however, it is likely that patient related factors and the progression of the underlying valvular disease pathology contributed to the event.Edwards lifesciences will continue to monitor all reported events.No further actions are required at this time.
 
Event Description
It was reported via the implant patient registry that a 34mm mitral ring, implanted for two (2) years and 11 months, was explanted due to severe recurrent regurgitation.The explanted device was replaced with a 25mm bioprosthetic valve.The valve was properly positioned and there was free movement and coaptation of the bioprosthetic valve leaflets.The patient also received a 23mm 8300ab aortic valve during the procedure.Intraoperative tee showed properly positioned and functioning aortic and mitral valve bioprostheses without any paravalvular or central leaks.The patient tolerated the procedure well.
 
Manufacturer Narrative
Corrected data: f10, h6.Reference capa-(b)(4).
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
COSGROVE-EDWARDS ANNULOPLASTY SYSTEM
Type of Device
RING, ANNULOPLASTY
Manufacturer (Section D)
EDWARDS LIFESCIENCES
1 edwards way
irvine CA 92614
MDR Report Key8962353
MDR Text Key161056973
Report Number2015691-2019-03300
Device Sequence Number1
Product Code KRH
Combination Product (y/n)N
PMA/PMN Number
K923367
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type health professional,other
Type of Report Initial,Followup
Report Date 08/13/2019
1 Device was Involved in the Event
1 Patient was Involved in the Event
Is this an Adverse Event Report? Yes
Is this a Product Problem Report? No
Device Operator Health Professional
Device Expiration Date06/26/2021
Device Model Number4600
Was Device Available for Evaluation? No
Initial Date Manufacturer Received 08/13/2019
Initial Date FDA Received09/04/2019
Supplement Dates Manufacturer Received07/23/2020
Supplement Dates FDA Received10/12/2020
Is This a Reprocessed and Reused Single-Use Device? No
Patient Sequence Number1
Patient Outcome(s) Required Intervention;
Patient Age59 YR
-
-